These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20562698)

  • 21. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care.
    Koller AK; Krebs S; Dörje F
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new method to obtain and present complete information on the compatibility: study of its validity for eight binary mixtures of morphine with drugs frequently used in palliative care.
    Vermeire A; Remon JP; Schrijvers D; Demeulenaere P
    Palliat Med; 2002 Sep; 16(5):417-24. PubMed ID: 12380660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical and chemical compatibility of daptomycin with nine medications.
    Lai JJ; Brodeur SK
    Ann Pharmacother; 2004 Oct; 38(10):1612-6. PubMed ID: 15328397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients.
    Canann D; Tyler LS; Barker B; Condie C
    Am J Health Syst Pharm; 2009 Apr; 66(8):727-9. PubMed ID: 19336832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a compatibility chart for intravenous Y-site drug administration in a pediatric intensive care unit.
    Manrique-Rodríguez S; Sánchez-Galindo A; Mora-García T; Fernandez-Llamazares CM; Echarri-Martínez L; López-Herce J; Rodríguez-Gómez M; Bellón-Cano JM; Sanjuro-Sáez M
    J Infus Nurs; 2012; 35(2):109-14. PubMed ID: 22382795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for continuous infusion medications in the neonatal intensive care unit.
    Santeiro ML; Stromquist C; Coppola L
    Ann Pharmacother; 1992 May; 26(5):671-4. PubMed ID: 1591428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability.
    Dickman A; Bickerstaff M; Jackson R; Schneider J; Mason S; Ellershaw J
    BMC Palliat Care; 2017 Mar; 16(1):22. PubMed ID: 28335763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of binary, ternary and quaternary mixtures for induction and maintenance of opioid free anesthesia.
    Tauste-Hernández B; Cortiñas-Sáenz M; Fernández-Ginés FD; Expósito-López JM
    Farm Hosp; 2021 Apr; 45(3):135-141. PubMed ID: 33941057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards more efficient use of intravenous lumens in multi-infusion settings: development and evaluation of a multiplex infusion scheduling algorithm.
    Doesburg F; Oelen R; Renes MH; Bult W; Touw DJ; Nijsten MW
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):206. PubMed ID: 32878609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical issues: preparation, administration, stability, and compatibility with other medications.
    Goldspiel BR
    Ann Pharmacother; 1994 May; 28(5 Suppl):S23-6. PubMed ID: 7915155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixing and compatibility guide for commonly used aerosolized medications.
    Burchett DK; Darko W; Zahra J; Noviasky J; Probst L; Smith A
    Am J Health Syst Pharm; 2010 Feb; 67(3):227-30. PubMed ID: 20101066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical stability of ondansetron hydrochloride with other drugs in admixtures via parenteral; a review.
    Estan-Cerezo G; Jiménez-Pulido I; Rodríguez Lucena FJ; Matoses Chirivella C; Soriano-Irigaray L; Navarro-Ruiz A
    Farm Hosp; 2017 Sep; 41(5):625-629. PubMed ID: 28847252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical Compatibility of Y-site Pediatric Drug Administration: A Call for Question of US Pharmacopeia Standards.
    Ross EL; Petty K; Salinas A; Bremmer J; Her C; Carpenter JF
    J Pediatr Pharmacol Ther; 2023; 28(1):84-92. PubMed ID: 36777987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured review.
    Baker J; Dickman A; Mason S; Ellershaw J
    PLoS One; 2018; 13(3):e0194236. PubMed ID: 29538455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compatibility of commonly used intravenous infusions in a pediatric intensive care unit.
    Wedekind CA; Fidler BD
    Crit Care Nurse; 2001 Aug; 21(4):45-51. PubMed ID: 11858688
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug incompatibilities in the adult intensive care unit of a university hospital.
    Marsilio NR; Silva Dd; Bueno D
    Rev Bras Ter Intensiva; 2016 Jun; 28(2):147-53. PubMed ID: 27410410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug infusions in a Swiss palliative care unit: assessment of frequent combinations in terms of clinical effectiveness, compatibility, and stability.
    Fusi-Schmidhauser T; Caronzolo D; Gamondi C
    Support Care Cancer; 2016 Dec; 24(12):4971-4978. PubMed ID: 27448404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization of infusion solutions to reduce the risk of incompatibility.
    Nemec K; Kopelent-Frank H; Greif R
    Am J Health Syst Pharm; 2008 Sep; 65(17):1648-54. PubMed ID: 18714112
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.